The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.

Drug price discounting is becoming more frequent and complex as industry and health care systems struggle to balance access and affordability. Leela Barham considers the pros and cons of keeping ...

Repatha: the frontline of US price battles Amgen's Repatha became the first in the new class of cholesterol-lowering PCSK9 inhibitor drugs to gain approval this year, getting the nod in Europe in ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

President Trump said that he's announcing increases on U.S. tariffs to match the tax rates that other countries charge on ...

“We don’t hold massive stockpiles of generic drugs in the United States. It’s a fairly just ... drugmakers to pay Medicaid a rebate if the price of their drugs rises faster than the rate ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...